198064-66-3

Upstream product

• 198064-97-0 ethyl 8-(4-chlorophenyl)-8-oxo-7-(phenyoxycarbonyloxy)octanoate 
• 198064-91-4 ethyl 8-(4-chlorophenyl)-8-oxooctanoate 
• 108-90-7 chlorobenzene 
• 14113-02-1 ethyl 8-chloro-8-oxooctanoate 
• 198064-99-2 ethyl 6-[4-(4-chlorophenyl)-2-oxo-2,3-dihydro-5-oxazolyl]hexanoate 
• 198064-95-8 8-(4-chloro-phenyl)-7-hydroxy-8-oxo-octanoic acid ethyl ester 
• 198064-93-6 7-bromo-8-(4-chloro-phenyl)-8-oxo-octanoic acid ethyl ester 

Downstream Products

• 198064-68-5 6-[4-(4-chloro-phenyl)-2-(2-methyl-imidazol-1-yl)-oxazol-5-yl]-hexanoic acid ethyl ester 
• 198064-70-9 4-(4-chlorophenyl)-2-(2-methyl-1-imidazolyl)-5-oxazolehexanol 

Relevant academic research and scientific papers

Synthesis and biological activity of novel 5-(omega-aryloxyalkyl)oxazole derivatives as brain-derived neurotrophic factor inducers.

A novel series of 5-(omega-aryloxyalkyl)oxazole derivatives was prepared and their effects on brain-derived neurotrophic factor (BDNF) production were evaluated in human neuroblastoma (SK-N-SH) cells. Syntheses were performed by construction of an oxazole

Oxazole derivatives, their production and use

A novel compound of the formula: wherein R1 is a halogen atom, an optionally substituted heterocyclic, hydroxy, thiol or amino group; A is an optionally substituted acyl group, an optionally substituted heterocyclic group, an optionally substituted hydroxy group, or an optionally esterified or amidated carboxy group; B is an optionally substituted aromatic group; Y is a divalent aliphatic hydrocarbon group, or a salt thereof, which have an excellent insulin secertion-promoting and blood sugar-depressing effect, and useful in agents for diabetes.